BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 10933717)

  • 1. Human immunodeficiency virus type 1 induces apoptosis in CD4(+) but not in CD8(+) T cells in ex vivo-infected human lymphoid tissue.
    Grivel JC; Malkevitch N; Margolis L
    J Virol; 2000 Sep; 74(17):8077-84. PubMed ID: 10933717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bystander CD4+ T lymphocytes survive in HIV-infected human lymphoid tissue.
    Grivel JC; Biancotto A; Ito Y; Lima RG; Margolis LB
    AIDS Res Hum Retroviruses; 2003 Mar; 19(3):211-6. PubMed ID: 12689413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Segregation of R5 and X4 HIV-1 variants to memory T cell subsets differentially expressing CD62L in ex vivo infected human lymphoid tissue.
    Gondois-Rey F; Grivel JC; Biancotto A; Pion M; Vigne R; Margolis LB; Hirsch I
    AIDS; 2002 Jun; 16(9):1245-9. PubMed ID: 12045489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo.
    Bounou S; Leclerc JE; Tremblay MJ
    J Virol; 2002 Feb; 76(3):1004-14. PubMed ID: 11773376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4(+) and CD8(+) T cell death during human immunodeficiency virus infection in vitro.
    Blanco J; Barretina J; Cabrera C; Gutiérrez A; Clotet B; Esté JA
    Virology; 2001 Jul; 285(2):356-65. PubMed ID: 11437669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of apoptosis of CD4+ and CD8+ T cells in tonsillar tissue in HIV type 1 infection.
    Røsok BI; Brinchmann JE; Stent G; Bjerknes R; Voltersvik P; Olofsson J; Asjö B
    AIDS Res Hum Retroviruses; 1998 Dec; 14(18):1635-43. PubMed ID: 9870316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of R77Q, R77A and R80A changes in Vpr on HIV-1 replication and CD4 T cell depletion in human lymphoid tissue ex vivo.
    Rajan D; Wildum S; Rücker E; Schindler M; Kirchhoff F
    AIDS; 2006 Apr; 20(6):831-6. PubMed ID: 16549966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between human immunodeficiency virus type 1 and vaccinia virus in human lymphoid tissue ex vivo.
    Vanpouille C; Biancotto A; Lisco A; Brichacek B
    J Virol; 2007 Nov; 81(22):12458-64. PubMed ID: 17804502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue.
    Grivel JC; Margolis LB
    Nat Med; 1999 Mar; 5(3):344-6. PubMed ID: 10086394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1.
    Grivel JC; Elliott J; Lisco A; Biancotto A; Condack C; Shattock RJ; McGowan I; Margolis L; Anton P
    AIDS; 2007 Jun; 21(10):1263-72. PubMed ID: 17545702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninfectious X4 but not R5 human immunodeficiency virus type 1 virions inhibit humoral immune responses in human lymphoid tissue ex vivo.
    Fitzgerald W; Sylwester AW; Grivel JC; Lifson JD; Margolis LB
    J Virol; 2004 Jul; 78(13):7061-8. PubMed ID: 15194782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral interactions in human lymphoid tissue: Human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation.
    Lisco A; Grivel JC; Biancotto A; Vanpouille C; Origgi F; Malnati MS; Schols D; Lusso P; Margolis LB
    J Virol; 2007 Jan; 81(2):708-17. PubMed ID: 17065205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1.
    Schweighardt B; Roy AM; Meiklejohn DA; Grace EJ; Moretto WJ; Heymann JJ; Nixon DF
    J Virol; 2004 Sep; 78(17):9164-73. PubMed ID: 15308712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue.
    Penn ML; Grivel JC; Schramm B; Goldsmith MA; Margolis L
    Proc Natl Acad Sci U S A; 1999 Jan; 96(2):663-8. PubMed ID: 9892690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct patterns of Bcl-2 expression occur in R5- and X4-tropic HIV-1-producing lymphoid tissue cells infected ex vivo.
    Haas MK; Levy DN; Folkvord JM; Connick E
    AIDS Res Hum Retroviruses; 2015 Mar; 31(3):298-304. PubMed ID: 25353356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells.
    Jekle A; Keppler OT; De Clercq E; Schols D; Weinstein M; Goldsmith MA
    J Virol; 2003 May; 77(10):5846-54. PubMed ID: 12719578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertussis toxin B-oligomer dissociates T cell activation and HIV replication in CD4 T cells released from infected lymphoid tissue.
    Alfano M; Grivel JC; Ghezzi S; Corti D; Trimarchi M; Poli G; Margolis L
    AIDS; 2005 Jul; 19(10):1007-14. PubMed ID: 15958831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The simian immunodeficiency virus deltaNef vaccine, after application to the tonsils of Rhesus macaques, replicates primarily within CD4(+) T cells and elicits a local perforin-positive CD8(+) T-cell response.
    Stahl-Hennig C; Steinman RM; Ten Haaft P; Uberla K; Stolte N; Saeland S; Tenner-Racz K; Racz P
    J Virol; 2002 Jan; 76(2):688-96. PubMed ID: 11752159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Fas/FasL system and T cell apoptosis in HIV-1-infected lymphoid tissue during highly active antiretroviral therapy.
    Dyrhol-Riise AM; Stent G; Røsok BI; Voltersvik P; Olofsson J; Asjö B
    Clin Immunol; 2001 Nov; 101(2):169-79. PubMed ID: 11683576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.